Literature DB >> 20537377

HIV drugs for treatment, and for prevention.

François Dabis1, Marie-Louise Newell, Bernard Hirschel.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20537377     DOI： 10.1016/S0140-6736(10)60838-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health.

Authors:  Susan Kippax; Niamh Stephenson
Journal:  Am J Public Health       Date:  2012-05       Impact factor: 9.308

2.  The role of the health system in HIV treatment-as-prevention.

Authors:  Till Bärnighausen
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

3.  Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.

Authors:  Richard J Lessells; Portia C Mutevedzi; Graham S Cooke; Marie-Louise Newell
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.

Authors:  Sten H Vermund; Sarah J Fidler; Helen Ayles; Nulda Beyers; Richard J Hayes
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

5.  "Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya.

Authors:  Jane M Simoni; Kristin Beima-Sofie; George Wanje; Zahra H Mohamed; Kenneth Tapia; R Scott McClelland; Rodney J Y Ho; Ann C Collier; Susan M Graham
Journal:  J Int Assoc Provid AIDS Care       Date:  2021 Jan-Dec

Review 6.  Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

Authors:  Ellen 't Hoen; Jonathan Berger; Alexandra Calmy; Suerie Moon
Journal:  J Int AIDS Soc       Date:  2011-03-27       Impact factor: 6.707

7.  The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model.

Authors:  Bruno Ventelou; Yves Arrighi; Robert Greener; Erik Lamontagne; Patrizia Carrieri; Jean-Paul Moatti
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.

Authors:  Jan Ac Hontelez; Marie-Louise Newell; Ruth M Bland; Kristen Munnelly; Richard J Lessells; Till Bärnighausen
Journal:  Hum Resour Health       Date:  2012-10-30

9.  Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study.

Authors:  Jan A C Hontelez; Mark N Lurie; Till Bärnighausen; Roel Bakker; Rob Baltussen; Frank Tanser; Timothy B Hallett; Marie-Louise Newell; Sake J de Vlas
Journal:  PLoS Med       Date:  2013-10-22       Impact factor: 11.069

10.  Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study.

Authors:  Michael Evangeli; Marie-Louise Newell; Nuala McGrath
Journal:  BMC Public Health       Date:  2016-04-27       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.